|
1
|
Kelland L: The resurgence of
platinum-based cancer chemotherapy. Nat Rev Cancer. 7:3533–584.
2007. View
Article : Google Scholar
|
|
2
|
Chovanec M, Abu Zaid M, Hanna N, El-Kouri
N, Einhorn LH and Albany C: Long-term toxicity of cisplatin in
germ-cell tumor survivors. Ann Oncol. 28:2670–2679. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rybak LP, Mukherjea D, Jajoo S and
Ramkumar V: Cisplatin ototoxicity and protection: Clinical and
experimental studies. Tohoku J Exp Med. 219:177–186. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sheth S, Mukherjea D, Rybak LP and
Ramkumar V: Mechanisms of cisplatin-induced ototoxicity and
otoprotection. Front Cell Neurosci. 11:3382017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kursunluoglu G, Taskiran D and Kayali HA:
The investigation of the antitumor agent toxicity and capsaicin
effect on the electron transport chain enzymes, catalase activities
and lipid peroxidation levels in lung, heart and brain tissues of
rats. Molecules. 23:32672018. View Article : Google Scholar
|
|
6
|
Breglio AM, Rusheen AE, Shide ED,
Fernandez KA, Spielbauer KK, McLachlin MM, Hall MD, Amable L and
Cunningham LL: Cisplatin is retained in the cochlea indefinitely
following chemotherapy. Nat Commun. 8:16542017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Moroso MJ and Blair RL: A review of
cis-platinum ototoxicity. J Otolaryngol. 12:365–379.
1983.PubMed/NCBI
|
|
8
|
Sakamoto M, Kaga K and Kamio T: Extended
high-frequency ototoxicity induced by the first administration of
cisplatin. Otolaryngol Head Neck Surg. 122:828–833. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Waissbluth S and Daniel SJ:
Cisplatin-induced ototoxicity: Transporters playing a role in
cisplatin toxicity. Hear Res. 299:37–45. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ravi R, Somani SM and Rybak LP: Mechanism
of cisplatin ototoxicity: Antioxidant system. Pharmacol Toxicol.
76:386–394. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rybak LP, Ravi R and Somani SM: Mechanism
of protection by diethyldithiocarbamate against cisplatin
ototoxicity: Antioxidant system. Fundam Appl Toxicol. 26:293–300.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
So H, Kim H, Kim Y, Kim E, Pae HO, Chung
HT, Kim HJ, Kwon KB, Lee KM, Lee HY, et al: Evidence that
cisplatin-induced auditory damage is attenuated by downregulation
of pro-inflammatory cytokines via Nrf2/HO-1. J Assoc Res
Otolaryngol. 9:290–306. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Vomund S, Schäfer A, Parnham MJ, Brüne B
and Knethen A: Nrf2, the master regulator of anti-oxidative
responses. Int J Mol Sci. 18:27722017. View Article : Google Scholar
|
|
14
|
Kopke RD, Liu W, Gabaizadeh R, Jacono A,
Feghali J, Spray D, Garcia P, Steinman H, Malgrange B, Ruben RJ, et
al: Use of organotypic cultures of Corti's organ to study the
protective effects of antioxidant molecules on cisplatin-induced
damage of auditory hair cells. Am J Otol. 18:559–571.
1997.PubMed/NCBI
|
|
15
|
Kim SJ, Park C, Han AL, Youn MJ, Lee JH,
Kim Y, Kim ES, Kim HJ, Kim JK, Lee HK, et al: Ebselen attenuates
cisplatin-induced ROS generation through Nrf2 activation in
auditory cells. Hear Res. 251:70–82. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Na HK and Surh YJ: Oncogenic potential of
Nrf2 and its principal target protein heme oxygenase-1. Free Radic
Biol Med. 67:353–365. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Vriend J and Reiter RJ: The
Keap1-Nrf2-antioxidant response element pathway: A review of its
regulation by melatonin and the proteasome. Mol Cell Endocrinol.
401:213–220. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li C, Xu T, Zhou P, Zhang J, Guan G, Zhang
H, Ling X, Li W, Meng F, Liu G, et al: Post-marketing safety
surveillance and re-evaluation of Xueshuantong injection. BMC
Complement Altern Med. 18:2772018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Huang Y, Guo B, Shi B, Gao Q and Zhou Q:
Chinese herbal medicine xueshuantong enhances cerebral blood flow
and improves neural functions in Alzheimer's disease mice. J
Alzheimers Dis. 63:1089–1107. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liang X, Yang Y, Huang Z, Zhou J, Li Y and
Zhong X: Panax notoginseng saponins mitigate cisplatin
induced nephrotoxicity by inducing mitophagy via HIF-1α.
Oncotarget. 8:102989–103003. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu X, Huang Z, Zou X, Yang Y, Qiu Y and
Wen Y: Panax notoginseng saponins attenuates
cisplatin-induced nephrotoxicity via inhibiting the mitochondrial
pathway of apoptosis. Int J Clin Exp Pathol. 7:8391–8400.
2014.PubMed/NCBI
|
|
22
|
Liu X, Huang Z, Zou X, Yang Y, Qiu Y and
Wen Y: Possible mechanism of PNS protection against
cisplatin-induced nephrotoxicity in rat models. Toxicol Mech
Methods. 25:347–354. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu SJ and Zhou SW: Panax
notoginseng saponins attenuated cisplatin-induced
nephrotoxicity. Acta Pharmacol Sin. 21:257–260. 2000.PubMed/NCBI
|
|
24
|
Hu S, Wu Y, Zhao B, Hu H, Zhu B, Sun Z, Li
P and Du S: Panax notoginseng saponins protect cerebral
microvascular endothelial cells against oxygen-glucose
deprivation/reperfusion-induced barrier dysfunction via activation
of PI3K/Akt/Nrf2 antioxidant signaling pathway. Molecules.
23:27812018. View Article : Google Scholar
|
|
25
|
Kalinec G, Thein P, Park C and Kainec F:
HEI-OC1 cells as a model for investigating drug cytotoxicity. Hear
Res. 335:105–117. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kalinec GM, Webster P, Lim DJ and Kalinec
F: A cochlear cell line as an in vitro system for drug ototoxicity
screening. Audiol Neurootol. 8:177–189. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Unoki T, Akiyama M, Kumagai Y, Gonçalves
FM, Farina M, da Rocha JBT and Aschner M: Molecular pathways
associated with methylmercury-induced Nrf2 modulation. Front Genet.
9:3732018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hill JM, Loeb E, MacLellan A, Hill NO,
Khan A and King JJ: Clinical studies of platinum coordination
compounds in the treatment of various malignant diseases. Cancer
Chemother Rep. 59:647–659. 1975.PubMed/NCBI
|
|
29
|
Hill JM and Speer RJ: Organo-platinum
complexes as antitumor agents (review). Anticancer Res. 2:173–186.
1982.PubMed/NCBI
|
|
30
|
Sun CY, Zhang QY, Zheng GJ and Feng B:
Phytochemicals: Current strategy to sensitize cancer cells to
cisplatin. Biomed Pharmacother. 110:518–527. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cepeda V, Fuertes MA, Castilla J, Alonso
C, Quevedo C and Pérez JM: Biochemical mechanisms of cisplatin
cytotoxicity. Anticancer Agents Med Chem. 7:3–18. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Trendowski MR, El Charif O, Dinh PC Jr,
Travis LB and Dolan ME: Genetic and modifiable risk factors
contributing to cisplatin-induced toxicities. Clin Cancer Res.
25:1147–1155. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Travis LB, Fossa SD, Sesso HD, Frisina RD,
Herrmann DN, Beard CJ, Feldman DR, Pagliaro LC, Miller RC, Vaughn
DJ, et al: Chemotherapy-induced peripheral neurotoxicity and
ototoxicity: New paradigms for translational genomics. J Natl
Cancer Inst. 106:dju0442014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Im GJ, Chang J, Lee S, Choi J, Jung HH,
Lee HM, Ryu SH, Park SK, Kim JH and Kim HJ: Protective role of
edaravone against cisplatin-induced ototoxicity in an auditory cell
line. Hear Res. 330:113–118. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kim SJ, Park C, Lee JN, Lim H, Hong GY,
Moon SK, Lim DJ, Choe SK and Park R: Erdosteine protects HEI-OC1
auditory cells from cisplatin toxicity through suppression of
inflammatory cytokines and induction of Nrf2 target proteins.
Toxicol Appl Pharmacol. 288:192–202. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang T, Guo R, Zhou G, Zhou X, Kou Z, Sui
F, Li C, Tang L and Wang Z: Traditional uses, botany,
phytochemistry, pharmacology and toxicology of Panax
notoginseng (Burk.) F.H. Chen: A review. J Ethnopharmacol.
188:234–258. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhao H, Han Z, Li G, Zhang S and Luo Y:
Therapeutic potential and cellular mechanisms of Panax
notoginseng on prevention of aging and cell
senescence-associated diseases. Aging Dis. 8:721–739. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Rybak LP, Mukherjea D and Ramkumar V:
Mechanisms of cisplatin-induced ototoxicity and prevention. Semin
Hear. 40:197–204. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Callejo A, Sedó-Cabezón L, Juan ID and
Llorens J: Cisplatin-induced ototoxicity: Effects, mechanisms and
protection strategies. Toxics. 3:268–293. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Op de Beeck K, Schacht J and Van Camp G:
Apoptosis in acquired and genetic hearing impairment: The
programmed death of the hair cell. Hear Res. 281:18–27. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yang PF, Song XY and Chen NH: Advances in
pharmacological studies of Panax notoginseng saponins on
brain ischemia-reperfusion injury. Yao Xue Xue Bao. 51:1039–1046.
2016.(In Chinese).
|
|
42
|
Su P, Wang L, Du SJ, Xin WF and Zhang WS:
Advance in studies of Panax notoginseng saponins on
pharmacological mechanism of nervous system disease. Zhongguo Zhong
Yao Za Zhi. 39:4516–4521. 2014.(In Chinese). PubMed/NCBI
|
|
43
|
Ooi BK, Goh BH and Yap WH: Oxidative
stress in cardiovascular diseases: Involvement of Nrf2 antioxidant
redox signaling in macrophage foam cells formation. Int J Mol Sci.
18:23362017. View Article : Google Scholar
|
|
44
|
Lourenço Dos Santos S, Petropoulos I and
Friguet B: The oxidized protein repair enzymes methionine sulfoxide
reductases and their roles in protecting against oxidative stress,
in ageing and in regulating protein function. Antioxidants (Basel).
7:1912018. View Article : Google Scholar
|
|
45
|
Machado-Silva A, Cerqueira PG,
Grazielle-Silva V, Gadelha FR, Peloso Ede F, Teixeira SM and
Machado CR: How trypanosoma cruzi deals with oxidative stress:
Antioxidant defence and DNA repair pathways. Mutat Res Rev Mutat
Res. 767:8–22. 2016. View Article : Google Scholar : PubMed/NCBI
|
